Papers/PMID:32375340
Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.
International journal of molecular sciences2020The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
coenzyme Q10 — decreases serum leptin
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.Finding“Remarkably, a meta-analysis of included studies revealed significant reduction of leptin levels in individuals on CoQ10 supplementation when compared to those on placebo (SMD: −0.59 [95% CI: −0.98, −0.21]; I2 = 0%, p = 0.37).”
Quoted verbatim from Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- adults with metabolic syndrome; meta-analysis of 6 RCTs (318 participants)
Effect -0.59 standardised mean difference, 95% CI -0.98 to -0.21
Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.2020PMID:32375340Permalink